Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
about
How can mathematical models advance tuberculosis control in high HIV prevalence settings?Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisThe impact and cost of scaling up GeneXpert MTB/RIF in South AfricaPopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationOperations research in global health: a scoping review with a focus on the themes of health equity and impactCost-effectiveness of a tuberculosis active case finding program targeting household and neighborhood contacts in Cambodia.Diagnostic point-of-care tests in resource-limited settingsDiagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study.Comparison of the efficacies of loop-mediated isothermal amplification, fluorescence smear microscopy and culture for the diagnosis of tuberculosis.Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysisFeasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study.Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.Smear plus Detect-TB for a sensitive diagnosis of pulmonary tuberculosis: a cost-effectiveness analysis in an incarcerated population.Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis.Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosisEvaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis.Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.Chest radiographic findings of pulmonary tuberculosis in severely immunocompromised patients with the human immunodeficiency virusImpact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults.Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults.Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries.Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modellingDisparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
P2860
Q26824057-15581979-4B03-4572-9DCF-9CE1FC9E2EA0Q27015848-07CC3B41-B7A4-457C-84AD-CBE55D8FCE36Q28477855-94A1AA84-7A3F-4313-8A91-F82A4E5DD2B6Q28484044-4F896A09-D4A4-4A5C-B08E-893B17732509Q28485280-76C37DD9-0D2A-4368-8E89-DB054ED25AA5Q29994616-E9B939C4-B567-4AD1-BD9F-87FBD566EF4BQ33588518-176E6413-D534-4F1C-8F2E-D15B123D0168Q33590492-2E9E4206-88FC-4AE6-AF5F-B94CBE01865AQ33625883-259F2ED3-C2A2-41DD-BEBE-5AE4A8AF5D5DQ33678888-4C3FFF94-C252-4F07-9D4F-54AF6B675824Q33813107-F2D206E2-0256-40C6-8988-DCFB74FDF416Q33939165-A88A6F9C-3869-4B37-8D60-653E42AB5CD4Q33998704-E4F193C3-0D6D-4A59-8DA9-95ECB31BF9BBQ34373838-DCB36820-BD20-4440-A900-527D909BF18EQ34395434-A60EA148-EFF8-41C0-BFB1-34D56561E067Q34986773-2DA21E62-34AD-4177-AE8C-846E5C24C2E4Q35053198-98600B91-F240-49DA-A3D5-28E0385CA618Q35129505-A1295C13-D76C-4CD7-855A-E4F278F312F3Q35584415-1B99074F-CFE6-45B7-88C7-DE593C196339Q35850402-58B6BD68-C0B9-4289-811B-BF5FA690E4DFQ35907384-019EA378-63DF-4EAB-B96A-36812D41A262Q35941022-66DB9F2D-ED48-4A46-B063-4F847D18EDA3Q36326280-C76E8AAA-2276-40F1-8D5F-DF737EEC2D5CQ36837440-2907354E-1A4E-44E4-AE9C-F9420EE1E54BQ36950190-306E7F2C-EFE1-4124-B356-39EA8E2313AEQ37569237-02CEA702-C159-4C70-A3A3-6219C5D62905Q37659683-5EC689D1-C677-4466-ACF0-8E79FD4BDEABQ38059894-E3C5E1C9-D07A-4341-B1B5-18D261FC4F91Q42546968-5CEA9C0B-C6B5-465F-954E-5CCAA45A87EBQ55016083-D23CA549-AE16-466D-828D-FD74F7AE696A
P2860
Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
@en
type
label
Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
@en
prefLabel
Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
@en
P2093
P1476
Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
@en
P2093
P304
P577
2008-09-01T00:00:00Z